HCW Biologics Inc. (NASDAQ:HCWB) announced new research published in Science Advances indicating that its compound HCW9206 may improve the production of CAR-T cell therapies. The study was carried out ...

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into ...

The approach relies on a specially engineered scaffold that links three naturally occurring cytokines known to promote immune memory.

To turbocharge disease-specific immune responses in patients, CAR-T cells are produced by removing a person's immune T cells ...

ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...

Multiplex assay tech detects multi-biomolecules in single samples on xMAP/CBA, with high sensitivity and consistency ...

Please provide your email address to receive an email when new articles are posted on . The excessive production of proinflammatory cytokines may drive the symptoms of long COVID due to a genetic ...

No potential conflict of interest relevant to this letter was reported. Gaestel M. What goes up must come down: molecular basis of MAPKAP kinase 2/3-dependent regulation of the inflammatory response ...

Early results from the United Kingdom's RECOVERY trial this summer were a welcome piece of good news in the midst of the COVID-19 pandemic. Critically ill patients on ventilators who received ...